Trump officials said industry didn't want FDA's stricter vaccine guidance, but the leading developer says they never discussed it
There are four weeks to the election. Senior Trump officials are now citing industry opposition as the reason they are blocking the FDA from making official their proposed EUA+ vaccine guidelines, which, if enforced, would dim the possibility of a pre-Election Day approval.
These revelations come from a pair of new reports out last night from the New York Times and Politico. But almost as soon as they came out, industry insiders began pushing back on the allegations. Former FDA chief Scott Gottlieb said he had never heard in anyone in pharma express that view, and Pfizer CEO Albert Bourla said he had never discussed the issue with the White House.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 110,100+ biopharma pros reading Endpoints daily — and it's free.